Skip to main content
Erschienen in: Cancer Immunology, Immunotherapy 8/2015

01.08.2015 | Meeting Report

Second meeting of the Spanish Immunotherapy Group GEIT (Grupo Español de Inmunoterapia), January 16, 2015, in Zaragoza, Spain

verfasst von: Alberto Anel, Luis Martínez-Lostao, Julián Pardo

Erschienen in: Cancer Immunology, Immunotherapy | Ausgabe 8/2015

Einloggen, um Zugang zu erhalten

Excerpt

The Spanish Immunotherapy Group (GEIT) is a thematic group created in 2013 inside the Spanish Society for Immunology (SEI), which intends to promote research and dissemination of immunotherapy and to foster collaboration between basic and clinical researchers in this field, currently with 70 members. The second scientific meeting of the GEIT was organized by Alberto Anel and Julián Pardo under the auspices of the Institute of Health Research (IIS) of Aragon and its scientific director Angel Lanas, and moderated by Julián Pardo [Centre for Biomedical Research of Aragon (CIBA), Zaragoza] and Ignacio Melero [Centre for Applied Medical Research (CIMA), Pamplona], and took place on Friday January 16, 2015. The interest in the scientific program of the session was patent, involving 100 researchers, basic and clinical. This meeting was in part intended to foster ties with other scientific societies related to immunotherapy, since the GEIT is intended as a cross-society group, not restricted to members of the Spanish Society of Immunology (SEI). For this reason, and for their scientific reputation, Carlos Martín, member of the Spanish Society for Microbiology, Ana Ortiz, belonging to the Spanish Society for Rheumatology, and Marisol Soengas, member of the Spanish Association of Bio-Enterprises, were invited as speakers. …
Metadaten
Titel
Second meeting of the Spanish Immunotherapy Group GEIT (Grupo Español de Inmunoterapia), January 16, 2015, in Zaragoza, Spain
verfasst von
Alberto Anel
Luis Martínez-Lostao
Julián Pardo
Publikationsdatum
01.08.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Cancer Immunology, Immunotherapy / Ausgabe 8/2015
Print ISSN: 0340-7004
Elektronische ISSN: 1432-0851
DOI
https://doi.org/10.1007/s00262-015-1732-2

Weitere Artikel der Ausgabe 8/2015

Cancer Immunology, Immunotherapy 8/2015 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.